Phytochemicals and therapeutic potentials of Barleria lupulina
Abstract
A well-known herb Barleria lupulina is traditionally used as a medicinal and decorative plant. The various parts of this plant are reported to contain a range of phytoconstituents, including terpenes and terpenoidal compounds, iridoid glucosides, iridoid diglucosides, phenylpropanoid glucosides, and phenylethanoid glucosides. Antibacterial, antiarthritic, CNS depressive, anti-osteoporotic, antioxidant, anti-diabetic, and anti-inflammatory effects are present in isolated components and extract of B. lupulina. This in-depth analysis covers the traditional uses, phytochemistry, pharmacological use, and mechanism of action of B. lupulina.
References
Alipieva K, Korkina L, Orhan IE, Georgiev MI. Verbascoside: A review of its occurrence, biosynthesis and pharmacological significance. Biotechnol Adv. 2014; 32: 1065-76.
Amoo SO, Finnie JF, Van SJ. In vitro pharmacological evaluation of three Barleria species. J Ethnopharmacol. 2009; 121: 274-77.
Amoo SO, Ndhlala AR, Finnie JF, Van SJ. Antifungal, acetyl cholinesterase inhibition, antioxidant and phytochemical properties of three Barleria species. South African J Bot. 2011; 77: 435-45.
Ata SA, Bosch VD, Harwanik DJ, Pidwinski GE. Glutathione S-transferase and acetyl cholinesterase inhibiting natural products from medicinally important plants. Pure Appl Chem. 2007; 79: 2269-76.
Ata SA, Kalahari KS, Samarsekera R. Chemical constituents of Barleria prionitis and their enzyme inhibitory and free radical scavenging activities. Phytochem Lett. 2009; 2: 37-44.
Balkwill MJ, Balkwill K. A preliminary analysis of distribution pattern in a large, pantropical genus, Barleria L. (Acanthaceae). J Biogeogr. 1998; 25: 95-110.
Balkwill MJ, Balkwill K. Delimitation and infrageneric classification of Barleria (Acanthaceae). Kew Bull. 1997; 52: 535-73.
Boros CA, Stermitz FR. Iridoids an updated review. Part 1. J Nat Prod. 1990; 53: 1055-47.
Byrne LT, Sasse JM, Skelton BW, Suksamrarn A, White AH. The minor iridoid glucosides of Barleria lupulina: Isolation, crystal structure and plant growth-inhibiting properties of 6-O-acetylshanzhiside methyl ester. Aust J Chem, 1987; 40, 785-94.
Chen JL, Blanc P, Stoddart CA. New iridoids from the medicinal plant Barleria prionitis with potent activity against respiratory syncytial virus. J Nat Prod. 1998; 61: 1295-97.
Chomnawang MT, Surassmo S, Nukoolkarn VS, Gritsanapan W. Antimicrobial effects of Thai medicinal plants against acne inducing bacteria. J Ethnopharmacol. 2005; 101: 330-33.
Chopra RN, Nayar SL, Chopra IC. Glossary of Indian medicinal plants. New Delhi, Academic Publishers, 1968, p 20.
Devi GV, Mathew PM. Cytological studies in the south Indian Acanthaceae: I. Genus Barleria L. Cytologia 1991; 56: 353-57.
Dey SK, Chattopadhyay S, Masanta NC. Antimicrobial activities of some medicinal plants of red and laterite zone of West Bengal, India. World J Pharm Pharmaceut Sc. 2014; 3: 719-34.
Dinda B, Debnath S, Harigaya Y. Naturally occurring iridoids: A review. Part 2. Chem Pharm Bull. 2007a; 55: 159-22.
Dinda B, Debnath S, Harigaya Y. Naturally occurring secoiridoids and bioacticity of naturally occurring iridoids and secoiridoids: A review. Part 1. Chem Pharm Bull. 2007b; 55: 689-28.
Doss A, Parivuguna V, Vijayasanthi M, Sruthi S. Antibacterial evaluation and phytochemical analysis of certain medicinal plants, Western Ghats Coimbatore. J Res Biol. 2011; 1: 24-29.
Eisai PT. Medicinal herb index in Indonesia. Jakarta, PT Eisai Indonesia, 1995, pp 247-48.
Jaiswal SK, Dubey MK, Das S. Evaluation of iridoid glycosides from leaves of Barleria prionitis as an antidiarrhoeal activity: An ethnopharmacological study. Int J Pharmac Sci. 2010; 2: 680-86.
Kanchanapoom T, Kasai R, Yamasaki K. Iridoid glucosides from Barleria lupulina. Phytochemistry 2001; 58: 337-41.
Kim KH, Park YJ, Chung KH, Richard Yip ML, Clardy J, Senger D, Cao S. Iridoid glycosides from Barleria lupulina. J Nat Prod. 2015a; 78: 320-24.
Kim K.H, Clardy J, Senger D, Cao S. Chakyunglupulins A and B two novel 4,8,8-trimethylcyclooct-2-enone derivatives from Barleria lupulina. Tetrahedron Lett. 2015b; 56: 2732-34.
Kim KH, Seuong RL, Clardy J, Senger DR, Cao S. Iridoid and phenylethanoid glycosides from the aerial parts of Barleria lupulina. Brazilian J Pharmacog. 2016; 26: 281-84.
Krishnaraju AV, Rao TV, Vanisree M, Tsay HS, Subbaraju GV. Assessment of bioactivity of Indian medicinal plants using brine shrimp (Artemia salina) lethality assay. Int J Appl Sci Eng. 2003; 3: 125-34.
Kumari R, Dubey RC. Phytochemical analysis and antibacterial and cytotoxic properties of Barleria lupulina Lindl. extracts. J Plant Pathol Microbiol. 2016a; 7: 1-6.
Kumari R, Dubey RC. HPTLC and GC-MS profile of Barleria lupulina Lindl extracts and their effect on enteric bacterial pathogens. J Appl Pharm. 2016b; 8: 61-68.
Kumari R, Kumar S, Kumar A, Goel K, Dubey RC. Antibacterial, antioxidant and immunomodulatory properties in extracts of Barleria lupulina Lindl. BMC Complement Altern Med. 2017; 17: 484-95.
Lans C, Harper T, Georges K, Bridgewater E. Medicinal and ethno veterinary remedies of hunters Trinidad. BMC Complement Altern Med. 2001; 1: 10-27.
Lekhak MM, Patil SS, Deshmukh PV, Lekhak UM, Kumar V, Rastogi A. Genus Barleria L. (Acanthaceae): A review of its, taxonomy, cytogenetics, phytochemistry and pharmacological potential. J Pharm Pharmacol. 2022; 74: 812-42.
Makholela T, Bank H, Balkwill K. A preliminary study of allozyme variation in three rare and restricted endemic Barleria greenii (Acanthaceae) populations. Biochem Syst Ecol. 2003; 31: 141-54.
Mazumder PM. Paramaguru R, Mohanty A, Sasmal D. Evaluation of in vitro anticataract activity and aldose reductase potential of Barleria lupulina Lindl. Pharmacologia 2014; 5: 172-76.
Mazumder PM., Mondal A, Sasmal D, Arulmozhi S, Rathinavelusamy P. Evaluation of antiarthritic and immunomodulatory activity of Barleria lupulina. Asian Pac J Trop Biomed. 2012; 2: S1400-06.
Moin S, Babu SS, Mahalakshmipriya A. In vitro callus produc-tion and antibacterial activity of Barleria lupulina Lindl. Asian Pac J Molec Biol Biotech. 2012; 20: 59-64.
Pattanayak S, Pal S, Mandal TP, Debnath PK, Bandyopadhyay SK. A comparative study of extract of succulent leaves of living plant with methanolic and aqueous extract of Barleria lupulina Lindl. against pathogenic microbes by disc diffusion and spectrophotometry. Explor Anim Med Res. 2014; 4: 148-57.
Sarmad M, Mahalakshmipriya A, Senthil K. Chemical composition and in-vitro antimicribial activity of Barleria lupulina essential oil. J Herbs Spices Med Plants. 2012; 18: 101-09.
Sawangjaroen N, Phongpaichit S, Subhadhirasukul S, Visutthi M, Srisuwan N, Thammapalred N. The anti-amoebic activity of some medicinal plants used by AIDS patients in southern Thailand. Parasitol Res. 2006; 98: 588-92.
Sawarkar HA, Bawankar RD. Genus Berleria: A review of traditional uses, phytochemistry, pharmacology and structure activity relationship. Invent Rapid Enthopharmacol. 2022; 2022.
Senger DR, Cao S. Diabetic wound healing and activation of Nrf2 by herbal medicine. J Nat Sci. 2016; 2: e247.
Senger DR, Hoang MV, Kim KH., Li C., Cao S. Anti-inflammatory activity of Barleria lupulina: Identification of active compounds that activate the Nrf2 cell defense pathway, organize cortical actin, reduce stress fibers, and improve cell junctions in microvascular endothelial cells. J Ethnopharmacol. 2016; 193: 397-407.
Shedange SM, Yadav SR. Revision of the genus, Barleria (Acanthaceae) in India. Rheedea 2010; 20: 81-130.
Singh A, Dhariwal S, Navneet. Pharmaceutical applications of Barleria lupulina Lindl. Pharmaceutical applications of natural products. First ed. Tirruvanamalai, JPS publications 2016, pp 107-15.
Singh B, Bani S, Gupta DK, Kaul A. Anti-inflammatory activity of TAF an active fraction from the plant Barleria prionitis Linn. J Ethnopharmacol. 2003; 85: 187-93.
Suba V, Murugesan T, Pal M, Mandal SC, Saha BP. Antiulcer activity of methanol fraction of Barleria lupulina Lindl. in animal models. Phytother Res. 2004; 18: 925-29.
Suba V, Murugesan T, Tao RB. Anti-diabetic potentials of Barleria lupulina extracts in rats. Phytomedicine 2004; 11: 202-05.
Suba V, Murugesan T, Tao RB. Anti-inflammatory, analgesic and antiperoxidative efficacy of Barleria lupulina Lindl extracts. Phytother Res. 2005; 19: 695-99.
Suba V, Murugesan T, Tao RB. Neuropharmacological profile of Barleria lupulina Lindl extract in animal model. J Ethnopharmacol. 2002; 81: 251-55.
Suhaimy NWI, Gani SSA, Zaidan UH, Halmi MIE, Bawon P. Optimizing conditions for microwave assisted extraction of polyphenolic content and antioxidant activity of Barleria lupulina Lindl. Plants 2021; 10: 682.
Suksamrarn A. Iridoid glucosides from Barleria lupulina. J Nat Prod. 1986; 49: 179.
Suksamrarn, S, Wongkrajang K, Kirtikara K., Suksamrarn A. Iridoid glucosides from flowers of Barleria lupulina. Planta Med. 2003; 69: 877-79.
Sur PK, Das PK. Radioprotective and anti-clastogenic effect of Barleria lupulina Lindl. extract against γ(gamma)-ray (1.2 Gy) induced mitotic chromosomal aberrations of laboratory mice Mus musculus. and its effect on fish tumour induced after γ-irradiation. J Res Biol. 2012; 2: 439-47.
Tuntiwachwuttikul P, Panchroen O, Taylor WC. Iridoid glucosides of Barleria lupulina. Phytochemistry 2001; 58:337-41.
Wanikiat P, Panthong A, Sujayanon P, Yoosook C, Rossi AG, Reutrakul V. The anti-inflammatory effects and the inhibition of neutrophil responsiveness by Barleria lupulina and Clinacanthus nutans extracts. J Ethnopharmacol. 2008; 116: 234–44.
Widyowati R, Tezuka Y, Miyahara T, Awale S, Kadota S. Alkaline phosphatase (ALP) enhancing iridoid glucosides from Indonesian medicinal plants Barleria lupulina. Nat Prod Commun. 2010; 5: 1711-16.
Yang HX, Liu QP, Zhou YX, Chen YY, An P, Xing YZ, Zhang L. Jia M, Zhang H. Forsythiasides: A review of the pharmacological effects. Frontiers in Cardiovas Med. 2020; 9: 971491.
Yoosook C, Panpisutchai Y, Chaichana S. Evaluation of anti-HSV-2 activities of Barleria lupulina and Clinacanthus mutans. J Ethnopharmacol. 1999; 67: 179-87.
Zhu M, Zhu H, Tan N. Central anti-fatigue activity of verbascoside. Neurosci Lett. 2016; 616: 75-79.
